11-36280717-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014186.4(COMMD9):āc.172G>Cā(p.Glu58Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000025 in 1,598,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014186.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COMMD9 | NM_014186.4 | c.172G>C | p.Glu58Gln | missense_variant | 2/6 | ENST00000263401.10 | NP_054905.2 | |
COMMD9 | NM_001307937.2 | c.145G>C | p.Glu49Gln | missense_variant | 3/7 | NP_001294866.1 | ||
COMMD9 | NM_001307932.2 | c.172G>C | p.Glu58Gln | missense_variant | 2/5 | NP_001294861.1 | ||
COMMD9 | NM_001101653.2 | c.52-2101G>C | intron_variant | NP_001095123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COMMD9 | ENST00000263401.10 | c.172G>C | p.Glu58Gln | missense_variant | 2/6 | 1 | NM_014186.4 | ENSP00000263401.5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152262Hom.: 0 Cov.: 33
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1446392Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 719036
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.172G>C (p.E58Q) alteration is located in exon 2 (coding exon 2) of the COMMD9 gene. This alteration results from a G to C substitution at nucleotide position 172, causing the glutamic acid (E) at amino acid position 58 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at